Metabolic & weight health
RESHAPE

Metabolic & weight health

The metabolic reset protocol.

About this protocol

GLP-1-based metabolic support with bloodwork-driven clinical oversight. RESHAPE treats the root cause, not just the symptom.

Who it's for: Adults with metabolic weight challenges, insulin resistance, or documented need for GLP-1 intervention — physician-supervised.

What's in RESHAPE START / RESHAPE PRO

RESHAPE START / RESHAPE PRO is the RESHAPE-aligned protocol. Pick it as your 1 protocol at Foundation, or pair it with additional protocols at Optimizer (2 total) or Elite (3 total).

Semaglutide (RESHAPE START)

GLP-1 receptor agonist — entry tier

A synthetic GLP-1 analog, FDA-approved as Wegovy (chronic weight management) and Ozempic (type 2 diabetes). Once-weekly subcutaneous dosing. Suppresses appetite at the hypothalamus, slows gastric emptying, and supports glucose-dependent insulin secretion.

Tirzepatide (RESHAPE PRO)

Dual GIP / GLP-1 receptor agonist — advanced tier

A dual-mechanism agonist of both GLP-1 and GIP receptors. FDA-approved as Mounjaro and Zepbound. Demonstrated 20%+ mean body-weight reduction in qualifying clinical-trial populations — a meaningful step beyond GLP-1 monotherapy.

What members are working toward

The following reflects areas of interest commonly reported by members and studied in the clinical literature. Results depend on individual health status, labs, and physician-directed care. Nothing below constitutes a treatment claim.

⚖️

Appetite & satiety regulation

GLP-1 receptor agonists like semaglutide and tirzepatide work by mimicking gut hormones that signal fullness to the brain. They are FDA-approved medications for chronic weight management in qualifying individuals, as determined by a physician.

🩸

Blood glucose management

GLP-1 medications were originally developed for type 2 diabetes management. They improve insulin sensitivity and reduce post-meal glucose spikes — both important markers tracked in the RESHAPE bloodwork panel.

❤️

Cardiovascular risk markers

Clinical trials with GLP-1 medications have shown favorable effects on cardiovascular risk markers in certain populations. Your lipid panel and metabolic markers are monitored throughout the protocol to track progress objectively.

🔄

Metabolic root cause approach

RESHAPE is not a standalone prescription service. Every member's protocol is built on bloodwork data — including fasting insulin and HbA1c — so the clinical approach addresses the underlying metabolic picture, not just the number on the scale.

Bloodwork panel

Every protocol begins with comprehensive labs. No prescription is issued without data.

HbA1c
Fasting insulin
Metabolic panel
Lipid panel
Thyroid panel
Metabolic & weight health

"Your biology has a halftime.
This is the strategy session."

Tier options

Starting at $199/mo

  • Foundation $199/mo — 1 protocol included. RESHAPE-aligned pick: RESHAPE START (Semaglutide).
  • Optimizer $349/mo — 2 protocols included. RESHAPE-aligned combo: RESHAPE PRO (Tirzepatide) + RECOVER (or ENERGIZER, DEEP REST).
  • Elite $549/mo — 3 protocols included. RESHAPE-aligned stack: RESHAPE PRO + any 2 of RECOVER, ENERGIZER, DEEP REST, SHARP MIND.

Pick any of the 12 protocols (5 base + 7 standard peptide) at any tier. Premium add-ons (VITALIZE, IMMUNE GUARD, MITOCORE) bill separately on top of any tier with clinical gating. The Halftime Baseline bloodwork panel ($249) is a separate onboarding deliverable, available at any tier.

Join the waitlist

Launching July 1, 2026

All prescriptions require physician evaluation. Compounded medications are not FDA-approved. Individual results vary. This is not medical advice.